Search Browse Earnings

Molecular Templates, Inc. — SlamSEC

Molecular Templates, Inc.

Pharmaceutical Preparations·AUSTIN, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.9M

-63.1% YoY

FY 2017

Adj. EBITDA

-$81.5M

-4334.5% margin

FY 2023

Net Income

-$92.7M

-4931.8% margin

FY 2023

EPS (Diluted)

-$24.69

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$32.2M

FY 2023

Total Debt

$36.2M

FY 2023

Net Debt

$4.0M

FY 2023

Enterprise Value

—

Debt / EBITDA

-0.0x

FY 2017

EV / EBITDA

—

Employees

—